POLYPLUS-TRANSFECTION
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
POLYPLUS-TRANSFECTION
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2001-01-01
Address:
Illkirch-graffenstaden, Alsace, France
Country:
France
Website Url:
http://www.polyplus-transfection.com
Total Employee:
11+
Status:
Active
Contact:
+33 3 90 40 61 80
Total Funding:
2.5 M EUR
Technology used in webpage:
Domain Not Resolving ReCAPTCHA V2 OVH WordPress Multisite
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-12-07 | Xpress Biologics | Xpress Biologics acquired by Polyplus-transfection | N/A |
Investors List
CIC Finance
CIC Finance investment in Venture Round - Polyplus-transfection
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Venture Round - Polyplus-transfection
Sudinnova
Sudinnova investment in Venture Round - Polyplus-transfection
Official Site Inspections
http://www.polyplus-transfection.com
- Host name: cluster023.hosting.cdn.ovh.net
- IP address: 46.105.204.23
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Polyplus-transfection"
Founding of Polyplus
Search for publications related to Polyplus transfection reagents. Life Sciences. Choose among a broad range of life science dedicated delivery solutions. ... Expanding into Belgium, contract …See details»
Polyplus® | Expertise - Quality - Support
Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy …See details»
Polyplus-transfection - Crunchbase Company Profile
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic …See details»
POLYPLUS-TRANSFECTION® QUALITY MANUAL
Organization ensure the continuity in the activities/work and customer satisfaction. Our Quality Management System Our organization, « Quality House » Manuel Qualité Version 7.3 ENG – …See details»
Sartorius to acquire Polyplus
Mar 31, 2023 Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors ; Agreed purchase price of approximately 2.4 billion euros; The life science group Sartorius, through its French listed …See details»
Sartorius Stedim Biotech to acquire Polyplus
Mar 31, 2023 Polyplus for approximately billion euros 2.4 private infrom vestors, including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg Pincus . Polyplus, with …See details»
Polyplus - ARCHIMED
Headquartered in France, Polyplus-transfection (Polyplus) was founded in 2001 as a spin-off from the Genetic Chemistry Laboratory in the Faculty of Pharmacy, University of Strasbourg. Polyplus is the leading biotechnology company that …See details»
Polyplus-transfection SA - Drug pipelines, Patents, Clinical trials ...
Mar 7, 2025 Polyplus has been expanding its focus beyond transfection reagents through acquisitions in adjacent technologies such as plasmid design, and protein and plasmid …See details»
Polyplus-transfection Company Profile - Craft
Polyplus-transfection has 5 employees across 2 locations and $3.23 m in total funding,. See insights on Polyplus-transfection including office locations, competitors, revenue, financials, …See details»
Learn More About Polyplus®
Polyplus has been driven to innovate solutions for nucleic acid delivery that power your science since January 2001. Originally named Polyplus-transfection, the company shortened the name to Polyplus in 2022, as we began to expand our …See details»
Polyplus-transfection - Funding, Financials, Valuation & Investors
Polyplus-transfection is funded by 3 investors. CIC Finance and Crédit Mutuel Innovation are the most recent investors. Polyplus-transfection has acquired Xpress Biologics on Dec 7, 2022 .See details»
Polyplus - Overview, News & Similar companies | ZoomInfo.com
Nov 2, 2020 Who is Polyplus. Polyplus-transfection SA is a biotechnology company founded in 2001 that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo …See details»
POLYPLUS TRANSFECTION INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for POLYPLUS TRANSFECTION INC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Sartorius to acquire Polyplus
Mar 31, 2023 an agreement to acquire Polyplus for approximately 2.4 billion euros private investorsfrom including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg …See details»
POLYPLUS TRANSFECTION Information - RocketReach
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction …See details»
Polyplus-transfection - Contacts, Employees, Board Members
Organization. Polyplus-transfection . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Polyplus Transfection - SelectScience
Polyplus-transfection SA is focused on developing reagents for intracellular delivery of biomolecules. Its expertise includes in vitro and in vivo delivery of genes, oligonucleotides, …See details»
Conference Call Acquisition of Polyplus - Sartorius
Apr 5, 2023 Polyplus` solutions for transfection and plasmids Sartorius` media, cell line and downstream capabilities Sartorius` solutions for process development and manufacturing. …See details»
Polyplus - Cell Culture Dish
Located close to the University of Strasbourg in Eastern France, Polyplus-transfection® is ISO 9001-certified since 2002 and supplies its wide range of reagents for the transfection of genes, …See details»
Quality management - Polyplus-transfection
This assures our global customers that Polyplus-transfection® has established reliable and effective processes for product development, manufacturing and delivery. Customer …See details»